Published in Int J Health Policy Manag on November 22, 2015
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
How to increase value and reduce waste when research priorities are set. Lancet (2014) 9.64
Cancer mortality in India: a nationally representative survey. Lancet (2012) 4.30
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst (2008) 3.24
A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst (2010) 3.14
Health care priority setting: principles, practice and challenges. Cost Eff Resour Alloc (2004) 2.59
Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J Immunol (2002) 1.93
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document. Ann Oncol (2010) 1.86
Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control (2009) 1.65
Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer (2013) 1.57
Human papillomavirus and HPV vaccines: a review. Bull World Health Organ (2007) 1.55
Impact of U.S. citizenship status on cancer screening among immigrant women. J Gen Intern Med (2005) 1.55
Analysis of cervical smears in a Muslim population. Ann Saudi Med (2004) 1.42
Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med (2001) 1.38
Knowledge attitudes and practices of cervical cancer screening among urban and rural Nigerian women: a call for education and mass screening. Eur J Cancer Care (Engl) (2011) 1.24
Cancer registry in Iran: a brief overview. Arch Iran Med (2008) 1.19
Prevention of invasive cervical cancer in the United States: past, present, and future. Cancer Epidemiol Biomarkers Prev (2012) 1.17
Cervical screening participation and risk among Swedish-born and immigrant women in Sweden. Int J Cancer (2011) 1.08
Patho-epidemiology of Cancer Cervix in Karachi South. Asian Pac J Cancer Prev (2007) 0.95
Epidemiology of cervical cancer and human papilloma virus infection among Iranian women - analyses of national data and systematic review of the literature. Gynecol Oncol (2012) 0.94
Health research priority setting in selected high income countries: a narrative review of methods used and recommendations for future practice. Cost Eff Resour Alloc (2014) 0.94
Overview of cervical cancer screening practices in the extended Middle East and North Africa countries. Vaccine (2013) 0.91
Cervical carcinoma in a Muslim community. Asian Pac J Cancer Prev (2007) 0.90
Human papillomavirus vaccines versus cervical cancer screening. Clin Oncol (R Coll Radiol) (2008) 0.90
Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran. Iran J Pharm Res (2014) 0.83
Knowledge and attitude of women regarding the human papillomavirus (HPV) infection, its relationship to cervical cancer and prevention methods. Med J Malaysia (2011) 0.82
Correlates between risk perceptions of cervical cancer and screening practice. Prev Med (2013) 0.82
A systematic review of economic aspects of cervical cancer screening strategies worldwide: discrepancy between economic analysis and policymaking. Asian Pac J Cancer Prev (2014) 0.82
Cervical screening strategies in resourced and resource-constrained countries. Best Pract Res Clin Obstet Gynaecol (2011) 0.81
Rate of opportunistic pap smear screening and patterns of epithelial cell abnormalities in pap smears in ajman, United arab emirates. Sultan Qaboos Univ Med J (2012) 0.81
Completeness and underestimation of cancer mortality rate in Iran: a report from Fars Province in southern Iran. Arch Iran Med (2015) 0.80
Management of precancerous cervical lesions in iran: a cost minimizing study. Asian Pac J Cancer Prev (2014) 0.79
Factors associated with delayed diagnosis of cervical cancer in Iran--a survey in Isfahan City. Asian Pac J Cancer Prev (2015) 0.79
Population-based cervical screening outcomes in Turkey over a period of approximately nine and a half years with emphasis on results for women aged 30-34. Asian Pac J Cancer Prev (2014) 0.77
Bibliographic review of research publications on access to and use of medicines in low-income and middle-income countries in the Eastern Mediterranean Region: identifying the research gaps. BMJ Open (2013) 1.01
Nurses exposure to workplace violence in a large teaching hospital in Iran. Int J Health Policy Manag (2014) 0.93
Improving Fraud and Abuse Detection in General Physician Claims: A Data Mining Study. Int J Health Policy Manag (2015) 0.84
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the risk of gastric cancer and its interaction with Helicobacter pylori infection. Iran Biomed J (2012) 0.83
Situation analysis of the National Comprehensive Cancer Control Program (2013) in the I. R. of Iran; assessment and recommendations based on the IAEA imPACT mission. Arch Iran Med (2014) 0.81
The Economic Burden of Breast Cancer in Iran. Iran J Public Health (2015) 0.79
The Incidence, Nature and Consequences of Adverse Events in Iranian Hospitals. Arch Iran Med (2015) 0.77
Oral hygiene status in a general population of Iran, 2011: a key lifestyle marker in relation to common risk factors of non-communicable diseases. Int J Health Policy Manag (2015) 0.77
Factors affecting professional delay in diagnosis and treatment of oral cancer in Iran. Arch Iran Med (2014) 0.77
Life and health satisfaction in adult population of Iran. Epidemiol Health (2016) 0.75
Policy Options to Reduce Fragmentation in the Pooling of Health Insurance Funds in Iran. Int J Health Policy Manag (2016) 0.75
A Qualitative Inquiry Into the Challenges of Medical Education for Retention of General Practitioners in Rural and Underserved Areas of Iran. J Prev Med Public Health (2016) 0.75
Factors affecting family physicians' drug prescribing: a cross-sectional study in Khuzestan, Iran. Int J Health Policy Manag (2014) 0.75
Geographical Disparities in the Health of Iranian Women: Health Outcomes, Behaviors, and Health-care Access Indicators. Int J Prev Med (2017) 0.75
Self-reported health related quality of life (HRQoL) and factors affecting health insured in Iran. Epidemiol Health (2016) 0.75
Association Between Breast Reconstruction Surgery and Quality of Life in Iranian Breast Cancer Patients. Acta Med Iran (2017) 0.75
Factors Associated With Unhealthy Snacks Consumption Among Adolescents in Iran's Schools. Int J Health Policy Manag (2017) 0.75
Travel Burden and Clinical Profile of Cancer Patients Admitted to the Cancer Institute of Iran in 2012. Arch Iran Med (2017) 0.75
'Seeking affluent neighbourhoods?' a time-trend analysis of geographical distribution of hospitals in the Megacity of Tehran. Health Policy Plan (2017) 0.75
Sensitivity of self-reported opioid use in case-control studies: Healthy individuals versus hospitalized patients. PLoS One (2017) 0.75
Is an Iranian Health Promoting School status associated with improving school food environment and snacking behaviors in adolescents? Health Promot Int (2017) 0.75
Changes in Socio-Economic Inequality in Neonatal Mortality in Iran Between 1995-2000 and 2005-2010: An Oaxaca Decomposition Analysis. Int J Health Policy Manag (2016) 0.75
Disability-Adjusted Life Years (DALY) for Cancers in Iran, 1990 to 2016: Review of Findings from the Global Burden of Disease Study. Iran J Public Health (2021) 0.75
'Seeking affluent neighbourhoods?' a time-trend analysis of geographical distribution of hospitals in the Megacity of Tehran. Health Policy Plan (2017) 0.75
Layer-by-layer assembly of graphene oxide on thermosensitive liposomes for photo-chemotherapy. Acta Biomater (2017) 0.75
Prevention and control of health care-associated infections in Iran: A qualitative study to explore challenges and barriers. Am J Infect Control (2016) 0.75